+154.1%
BBIO vs EPAM
-57.1%
+211.2%
-49.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.7% | -0.1% | -4.6% | -4.7% |
| 7D | -3.9% | -4.5% | +0.6% | -3.2% |
| 30D | -13.4% | +14.6% | -28.0% | -15.4% |
| 3M | +7.6% | +23.1% | -15.5% | +2.9% |
| 6M | -2.4% | -19.5% | +17.0% | +1.1% |
| YTD | -5.2% | -44.1% | +38.9% | +4.7% |
| 1Y | +36.9% | -25.2% | +62.1% | +41.3% |
| All | +154.1% | -57.1% | +211.2% | +192.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling